Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Receptor expression-enhancing protein 4 (REEP4) is an endoplasmic reticulum (ER) membrane protein characterized by a dual hairpin structure and a reticulon homology domain. REEP4 binds microtubules and is necessary for proper cell division, particularly by ensuring mitotic nuclear membrane reassembly and sequestering ER away from metaphase chromosomes. During mitosis, REEP4—together with its paralog REEP3—induces high-curvature ER tubules and positions the ER away from chromatin, roles that are physically separable through different protein regions. REEP4 has no known direct interactions with therapeutics and is not typically classified as a traditional drug target, receptor, or enzyme. Genetic disruption of REEP4 is linked to rare syndromes such as autosomal dominant spastic paraplegia 31 and hereditary lymphedema II. The protein plays a critical role in cell cycle-dependent ER remodeling and nuclear dynamics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Receptor expression-enhancing protein 4 (REEP4).